Financials
- Market Capitalization 3.39 B
- Employee 354
- Founded 2016
- CEO Frank Watanabe
- Website www.arcutis.com
- Headquarter Delaware, United States
- FIGI BBG00QN8K4M4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1584 | RCUS Arcus Biosciences, Inc. Common Stock | 28.08 USD | -2.90% | -7.17% | +15.03% | +190.08% | 3.53 B USD | ||
| 1600 | ALMS Alumis Inc. - Common Stock | 28.10 USD | -0.74% | +1.52% | +15.21% | +523.06% | 3.47 B USD | ||
| 1617 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.64 USD | +0.94% | +3.68% | +28.06% | +0.98% | 3.38 B USD | ||
| 1621 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 21.02 USD | -0.19% | -1.64% | +14.36% | +21.78% | 3.36 B USD |
Frequently asked questions about Arcutis Biotherapeutics, Inc. - Common stock
What is the Arcutis Biotherapeutics, Inc. - Common stock stock price today?
The current price of Arcutis Biotherapeutics, Inc. - Common stock (ARQT) is 27.12. Over the past 24 hours, the stock has changed by -2.24%. Follow the ARQT chart for real-time price dynamics.
What is the stock ticker of Arcutis Biotherapeutics, Inc. - Common stock?
Arcutis Biotherapeutics, Inc. - Common stock trades under the ticker ARQT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arcutis Biotherapeutics, Inc. - Common stock stock going up?
ARQT has changed by +3.12% over the last week, +10.15% over the last month, and +70.14% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Arcutis Biotherapeutics, Inc. - Common stock net income for the last quarter?
Arcutis Biotherapeutics, Inc. - Common stock reported net income of -11.29 M for the last quarter. The previous quarter showed 17.39 M, which means net income changed by -164.93%.
How many employees does Arcutis Biotherapeutics, Inc. - Common stock have?
As of the latest available data, Arcutis Biotherapeutics, Inc. - Common stock has 354 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arcutis Biotherapeutics, Inc. - Common stock EBITDA?
Arcutis Biotherapeutics, Inc. - Common stock EBITDA is -8.71 M, and its EBITDA margin is -8.26%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arcutis Biotherapeutics, Inc. - Common stock stock?
You can buy Arcutis Biotherapeutics, Inc. - Common stock (ARQT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arcutis Biotherapeutics, Inc. - Common stock stock?
Investing in Arcutis Biotherapeutics, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ARQT chart and related analysis on metatrader.com as part of your research.